ArticleFrontiers in oncology2022

Case report: Acquired neurotrophic tyrosine receptor kinase inhibitor resistance in a patient with pancreatic neuroendocrine carcinoma receiving entrectinib.

Wen-Chi Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.